In healthy children, Gal-3 presents no variations in age and gender, as opposed to other biomarkers that are also altered in the setting of myocardial fibrosis, such as ST2, NT-proBNP and troponin [81,82]. The gene discussed is LGALS3; the disease is Myocardial fibrosis.